11:10 AM EDT, 06/08/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts kicked off the week higher late Monday morning, lifting 0.82% to 1,874.41 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by semiconductor company Sequans Communications ( SQNS ) and biotech firm Evaxion ( EVAX ) , which rose 7% and 4.5% respectively. They were followed by accommodations booking company trivago (TRVG) and telecommunications company Nokia ( NOK ) , which increased 4.4% and 1.7% respectively.

The decliners from continental Europe were led by pharmaceutical company Novo Nordisk ( NVO ) and biopharmaceutical company Cellectis ( CLLS ) , which fell 2.9% and 2.3% respectively. They were followed by pharmaceutical company Sanofi ( SNY ) and biopharmaceutical company Grifols ( GRFS ) , which were down 2% each.

The gainers from the UK were led by biopharmaceutical companies Biodexa Pharmaceuticals ( BDRX ) and NuCana ( NCNA ) , which advanced 4.5% and 3.3% respectively. They were followed by oil and gas company BP (BP) and biopharmaceutical company Amarin ( AMRN ) , which were up 1.7% and 1.6% respectively.

The decliners from the UK and Ireland were led by biotech company Autolus Therapeutics ( AUTL ) and biopharmaceutical company Mereo BioPharma Group ( MREO ) , which dropped 4.2% and 2.4% respectively. They were followed by utilities company National Grid ( NGG ) and pharmaceutical company GSK (GSK), which lost 2% and 1.2% respectively.